Related references
Note: Only part of the references are listed.Activin-Like Kinase 5 (ALK5) Mediates Abnormal Proliferation of Vascular Smooth Muscle Cells from Patients with Familial Pulmonary Arterial Hypertension and Is Involved in the Progression of Experimental Pulmonary Arterial Hypertension Induced by Monocrotaline
Matthew Thomas et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Role of the TGF-β/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension
Ari L. Zaiman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension
Kwon-Ho Hong et al.
CIRCULATION (2008)
Inhibition of glycogen synthase kinase-3β is sufficient for airway smooth muscle hypertrophy
Huan Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gβγ-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3
Sebastien Taurin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cells
Kelly Schultz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Transforming growth factor-β1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells
A Sturrock et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1
YL Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Transforming growth factor-β induces airway smooth muscle hypertrophy
AM Goldsmith et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Dominant negative mutation of the TGF-β receptor blocks hypoxia-induced pulmonary vascular remodeling
YF Chen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
MK Holz et al.
CELL (2005)
Wnt/β-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy
DD Armstrong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy
LM Zhou et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension
XD Yang et al.
CIRCULATION RESEARCH (2005)
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension
E Marcos et al.
CIRCULATION RESEARCH (2004)
Mnk1 is required for angiotensin II - Induced protein synthesis in vascular smooth muscle cells
M Ishida et al.
CIRCULATION RESEARCH (2003)
Bovine distal pulmonary arterial media is composed of a uniform population of well-differentiated smooth muscle cells with low proliferative capabilities
L Stiebellehner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells
T Yamakawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Molecular mechanisms modulating muscle mass
DJ Glass
TRENDS IN MOLECULAR MEDICINE (2003)
Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth
S Haq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GSK-3β negatively regulates skeletal myotube hypertrophy
DR Vyas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
CL Antos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
XM Wang et al.
EMBO JOURNAL (2001)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
Glycogen synthase kinase 3β regulates GATA4 in cardiac myocytes
C Morisco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy
S Haq et al.
JOURNAL OF CELL BIOLOGY (2000)
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
JR Thomson et al.
JOURNAL OF MEDICAL GENETICS (2000)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)